biotech

AI

OpenAI adds biotech arm, chat lock, amid open‑source pressure

OpenAI buys Orchestra Bio, launches PIN‑protected chats, and confronts fast‑moving open‑source LLMs as internal agent activity raises security questions.

AI

VCs back SVB as AI-native biotech fund bets on small wins

Over 100 VCs sign a joint statement backing Silicon Valley Bank while biotech veteran Vijay Pande launches a lean AI‑focused fund, signaling a shift in venture betting.

Tech

New IP proposal collides with market-driven tech shifts

ITU's prescriptive New IP framework meets the reality of 5G cooperation, LEO convergence, and crypto-funded biotech, proving market forces win.

Tech

Ace Ping-Pong Robot Outplays Humans

Ace, a ping-pong robot with advanced tracking, joins a landscape of orbital interceptors and regulatory shifts in biotech.

AI

Claude’s new life‑science suite slashes research cycles

Anthropic upgrades Claude with Opus 4.5 and a dedicated life‑science toolkit, letting labs compress months‑long projects into hours.

AI

AI, Labs, and Power: The Week Tech Moved Fast and Raised

From lab‑grown sperm to custom AI bots and 600 kW chargers, new releases stretch capabilities and spark debate.